SENOKOT®•S Laxative Plus Stool Softener

Reduce dose or discontinue use if you experience abdominal pain, cramps or spasms and/or diarrhea. Do not use in the presence of fecal impaction (a large lump of dry, hard stool that develops in the rectum); undiagnosed, acute or persistent gastrointestinal complaints (e.g., abdominal pain, nausea, fever or vomiting); appendicitis; inflamed bowel or intestinal blockage. Consult a healthcare practitioner if symptoms continue to occur or worsen. As with all laxatives, do not take for more than one week. If laxatives are needed every day, consult a healthcare practitioner. Long-term use of stimulant laxatives should be avoided. Prolonged excessive use or misuse may precipitate the onset of atonic (non-functioning) colon. If rectal bleeding or failure to have a bowel movement (after use of a laxative) occurs, therapy should be discontinued as it may indicate a more serious condition – consult a physician. If there has been a sudden change in bowel movements that persists over a period of 2 weeks, consult a physician before using a laxative. Consult a healthcare practitioner prior to use if you have a kidney disorder, are pregnant or breastfeeding.

SENOKOT®•S should not be taken within two hours of another medicine as it may reduce the effectiveness of other medicine. Drugs that may interact with SENOKOT®•S include: cardiac medications such as cardiac glycosides (drugs that increase the force of contraction of the heart) or antiarrhythmic medications (drugs that restore the normal rhythm of the heart); mineral oil; thiazide diuretics (drugs used to treat high blood pressure), corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance.

Fertility, Pregnancy and Lactation: There are no reports of adverse or damaging effects during pregnancy or on the fetus associated with senna preparations when used in accordance to the recommended dosage schedule. However, as a consequence of experimental data concerning a genotoxic risk of several anthranoids (e.g., emodin and aloe-emodin) use is not recommended during pregnancy. Small amounts of active metabolites (rhein) are excreted in breast milk. A laxative effect in breast fed babies has not been reported. However, use during breastfeeding is not recommended as there is insufficient data on the excretion of metabolites in breast milk.

Overdose: The major symptoms of overdose/abuse of stimulant laxative, including those containing senna, are griping pain and severe diarrhea, leading to excessive water loss (dehydration) and possible electrolyte imbalance (i.e. hypokalemia). In case of overdose: call a Regional Poison Control Centre and/or your physician and/or your local emergency number immediately, or go to your local hospital emergency, even if you do not notice any signs or symptoms.

MEDICINAL INGREDIENTS: Standardized sennosides from senna and docusate sodium.

NON-MEDICINAL INGREDIENTS: cornstarch, D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake, guar gum, lecithin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, silicon dioxide, sodium benzoate, talc and titanium dioxide.

Store at 15-25°C.

SENOKOT®•S can be found at your local pharmacy and in many popular and convenient stores across Canada. Samples may be available through your family physician.

Please read and follow the information on the label to be sure this product is suitable for you.